Ucb SA Sustainability Reports
UCB S.A. is a global biopharmaceutical company focusing on the discovery and development of innovative medicines and solutions. Its core therapeutic areas of research and commercialization specialize in severe diseases within neurology and immunology.
Sector: Manufacturing
Country: Belgium
Exchange: Euronext Brussels
LEI: 2138008J191VLSGY5A09
FIGI: BBG001S6LBX9
27 reports from 2006 to 2025
